Opportunity
Simpler Grants.gov #HT942526BCRPEOHS
Era of Hope Scholar Award for Innovative Breast Cancer Research (FY26 BCRP)
Buyer
Dept. of the Army -- USAMRAA
Posted
May 04, 2026
Respond By
July 08, 2026
Identifier
HT942526BCRPEOHS
NAICS
541715
This opportunity supports innovative breast cancer research through a major federal grant: - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Defense Health Agency, Congressionally Directed Medical Research Programs (CDMRP) - Award Details: - Era of Hope Scholar Award under the FY26 Breast Cancer Research Program (BCRP) - Up to $4.9 million in total funding over a maximum of four years - Designed for early-career scientists with exceptional potential for leadership in breast cancer research - Key Requirements: - Principal Investigator (PI) must dedicate at least 25% of their time to breast cancer research - Research team must include two or more breast cancer consumer advocates - Research must address at least one of the BCRP's overarching challenges (e.g., prevention, metastasis, treatment innovation) or provide justification for exceptions - Products/Services Requested: - No specific products or OEMs; this is a research grant for scientific investigation and team support - Notable Aspects: - Focuses on supporting individuals, not specific projects - Strong emphasis on innovation, leadership potential, and consumer advocate involvement
Description
The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award supports early career individuals with significant potential to effect meaningful change in breast cancer. The award recognizes creative and innovative individuals rather than projects, focusing on the Principal Investigator's ability to think beyond conventional approaches. The PI must dedicate at least 25% of their time to breast cancer research during the award period, and the research team must include two or more breast cancer consumer advocates. The award provides funding of approximately $4.9 million for a maximum period of four years, with one expected award.